Infusystem (INFU) Fundamental Analysis: Revenue, Earnings & Valuation

0.56 / 10

Underperform

Evaluation yields 0.6/10, reflecting challenging financial health. Key positives: Cash-MV and Fixed assets turnover ratio, whereas limitations surface in Profit-MV and Net income-Revenue. This configuration appears challenging.

Analysis Checks(6/10)

Revenue-MV

Value0.05

Score1/3

Weight70.96%

1M Return-2.62%

ROA (%)

Value6.49

Score2/3

Weight-3.09%

1M Return0.10%

ROE (diluted) (YoY growth rate %)

Value11.00

Score3/3

Weight-27.44%

1M Return0.88%

Profit-MV

Value0.22

Score1/3

Weight12.25%

1M Return-0.42%

Net income-Revenue

Value-1.14

Score1/3

Weight78.17%

1M Return-3.05%

Fixed assets turnover ratio

Value2.92

Score2/3

Weight-1.78%

1M Return0.06%

Annualized net profit margin on total assets (%)

Value6.49

Score2/3

Weight-3.09%

1M Return0.10%

Asset-MV

Value-0.72

Score1/3

Weight108.21%

1M Return-4.53%

Cash-MV

Value-0.15

Score2/3

Weight-86.20%

1M Return2.46%

Net profit / Total profit (%)

Value62.38

Score3/3

Weight-47.98%

1M Return1.48%

Is INFU undervalued or overvalued?

INFU scores 0.56/10 on fundamentals and holds a Premium valuation at present. Backed by its 11.54% ROE, 4.62% net margin, 28.58 P/E ratio, 3.30 P/B ratio, and 190.91% earnings growth, these metrics solidify its Underperform investment rating.